Publicacións nas que colabora con Rafael Sierra Camerino (19)

2021

  1. Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

    Intensive Care Medicine, Vol. 47, Núm. 2, pp. 160-169

2019

  1. Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): An investigator-driven, open-label, randomized, noninferiority controlled trial

    Critical Care, Vol. 23, Núm. 1

  2. The association of cardiovascular failure with treatment for ventilator-associated lower respiratory tract infection

    Intensive Care Medicine, Vol. 45, Núm. 12, pp. 1753-1762

2018

  1. Comparison of European ICU patients in 2012 (ICON) versus 2002 (SOAP)

    Intensive Care Medicine, Vol. 44, Núm. 3, pp. 337-344

  2. Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study

    Intensive Care Medicine, Vol. 44, Núm. 9, pp. 1470-1482

2016

  1. Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome

    Critical Care, Vol. 20, Núm. 1

2015

  1. Incidence and prognosis of ventilator-associated tracheobronchitis (TAVeM): A multicentre, prospective, observational study

    The Lancet Respiratory Medicine, Vol. 3, Núm. 11, pp. 859-868

2014

  1. Infections, antibiotic treatment and mortality in patients admitted to ICUs in countries considered to have high levels of antibiotic resistance compared to those with low levels

    BMC Infectious Diseases, Vol. 14, Núm. 1

2012

  1. Programas de optimización de uso de antimicrobianos (PROA) en hospitales españoles: documento de consenso GEIH-SEIMC, SEFH y SEMPSPH

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 30, Núm. 1

  2. Programas de optimización de uso de antimicrobianos (PROA) en hospitales españoles: documento de consenso GEIH-SEIMC, SEFH y SEMPSPH

    Farmacia Hospitalaria, Vol. 36, Núm. 1

2011

  1. Community-acquired respiratory coinfection in critically III patients with pandemic 2009 influenza A(H1N1) virus

    Chest, Vol. 139, Núm. 3, pp. 555-562

  2. Health-care-associated bloodstream infections at admission to the ICU

    Chest, Vol. 139, Núm. 4, pp. 810-815

  3. Impact of obesity in patients infected with 2009 influenza A(H1N1)

    Chest, Vol. 139, Núm. 2, pp. 382-386

  4. Programs to optimize antimicrobial use (PROA) in Spanish hospitals: GEIH-SEIMC, SEFH and SEMPSPH consensus document

    Medicina Preventiva, Vol. 17, Núm. 3, pp. 29-39

  5. Severe pandemic (H1N1)v influenza A infection: Report on the first deaths in Spain

    Respirology, Vol. 16, Núm. 1, pp. 78-85

  6. Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection

    Intensive Care Medicine, Vol. 37, Núm. 2, pp. 272-283

2010

  1. Política de antibióticos en pacientes críticos

    Medicina Intensiva, Vol. 34, Núm. 9, pp. 600-608

2006

  1. Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: A prospective observational study

    Critical Care, Vol. 10, Núm. 3

2003

  1. Factors related to hospital stay among patients with nosocomial infection acquired in the intensive care unit

    Infection Control and Hospital Epidemiology, Vol. 24, Núm. 3, pp. 207-213